Leyi Yao
Zhanjiang, 524000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer.
Journal: Cancer letters
Published: February 27, 2026
Saquinavir induces pyroptosis through the OTUD5-JAK1-GSDME axis in hepatocellular carcinoma.
Journal: Free radical biology & medicine
Published: December 16, 2025
Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: February 27, 2025
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.
Journal: Oncogene
Published: February 26, 2025
UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma.
Journal: Free radical biology & medicine
Published: January 28, 2025
Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth.
Journal: Frontiers in pharmacology
Published: December 18, 2024
Research Progress on the Role and Mechanism of IL-37 in Liver Diseases.
Journal: Seminars in liver disease
Published: August 15, 2023
Plumbagin is a novel GPX4 protein degrader that induces apoptosis in hepatocellular carcinoma cells.
Plumbagin is a novel GPX4 protein degrader that induces apoptosis in hepatocellular carcinoma cells.
Journal: Free radical biology & medicine
Published: February 03, 2023
Induction of Heme Oxygenase-1 Modifies the Systemic Immunity and Reduces Atherosclerotic Lesion Development in ApoE Deficient Mice.
Journal: Frontiers in pharmacology
Published: November 05, 2021
Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system.
Journal: Journal of translational medicine
Published: September 07, 2021
Last Updated: 09/26/2026